Login / Signup

Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.

Wei ZhangJie ChengPengfei DiaoDongmiao WangWei ZhangHongbing JiangYanling Wang
Published in: British journal of cancer (2019)
Our findings revealed a novel therapeutic strategy of simultaneous LSD1 and JMJD3 inhibition against HNSCC.
Keyphrases
  • cancer therapy
  • signaling pathway
  • single cell
  • pi k akt